Xeris Biopharma Inc.

NASDAQ: XERS · Real-Time Price · USD
7.66
0.36 (4.93%)
At close: Aug 15, 2025, 3:59 PM
7.67
0.13%
After-hours: Aug 15, 2025, 07:25 PM EDT

Xeris Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-32M -45.08M -54.84M -63.11M -59.56M -64.4M -62.26M -61.8M -71.44M -77.78M -94.66M -132.52M -136.7M -138.03M -122.72M -93.79M -83.78M -80.37M
Depreciation & Amortization
11.87M 12.11M 12.18M 12.3M 12.98M 13.19M 13.16M 13.4M 13.12M 12.82M 12.67M 10.06M 7.32M 4.57M 1.88M 1.43M 1.49M 1.48M
Stock-Based Compensation
19.81M 19.04M 18.36M 17.54M 13.22M 11.92M 10.72M 10.71M 11.2M 11.42M 12.16M 12.14M 12.86M 12.22M 11.38M 10.78M 9.17M 8.73M
Other Working Capital
7.11M 8.84M 12M 24.81M 24.58M 26.25M 9.92M 2.22M -4.02M -9.62M -12.98M -3.51M -1.55M 4.52M 19.98M 9.53M 12.25M 4.88M
Other Non-Cash Items
-11.24M 13.3M 24.69M 20.93M 28.28M 8.72M -4.32M -7.84M -7.16M -2.15M 1.84M 8.53M 8.44M 3.9M 961K 3.12M 3.23M 3.17M
Deferred Income Tax
-3.32M -2.58M -2.27M -3.52M 2.64M 1.48M 789K 2.04M -798K -382K n/a 853K 845K 981K 1.11M 344K 556K 880K
Change in Working Capital
8.55M -4.08M -474K 17.83M -1.9M 1.93M -6.29M -27.13M -18.92M -24.79M -35.15M -15.03M -13.34M -3.63M 11.85M 662K -2.49M -9.47M
Operating Cash Flow
-6.33M -26.71M -36.98M -32.67M -38.98M -42.37M -48.21M -70.61M -73.76M -80.62M -102.89M -115.72M -120.58M -119.99M -95.53M -77.46M -71.83M -75.57M
Capital Expenditures
-307K -717K -868K -780K -1.04M -2.19M -2.26M -2.26M -2.09M -762K -508K -507K -638K -640K -1.08M -1.18M -852K -780K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a -16K n/a 38.47M 38.78M 39.01M 39.42M 1.18M 872K 654K
Purchase of Investments
-5M -10M -34.48M -34.48M -29.49M -24.49M -43.74M -43.74M -43.74M -43.73M 16K -12.22M -22.86M -35.1M -43.02M -41.15M -108.2M -95.98M
Sales Maturities Of Investments
25.24M 35.24M 40.24M 45M 45M 45M 40M 34.3M 26.18M 28.29M 34.98M 36.19M 58.75M 75.65M 103.6M 110.94M 98.49M 86.98M
Other Investing Acitivies
n/a 5M -14.49M 514K 15.51M 20.51M -3.74M -18.74M -26.86M -36.87M 13.59M 11.85M 4.66M 4.46M -2.69M -1.18M -852K 16.86M
Investing Cash Flow
19.93M 24.52M 4.88M 9.73M 14.48M 18.32M -6M -11.7M -19.65M -16.23M 34.46M 61.9M 73.69M 78.38M 97.96M 68.61M -10.57M -9.78M
Debt Repayment
n/a n/a 38.17M 38.17M 38.17M 38.17M n/a 48.92M 48.92M 48.92M 102.72M 53.8M 53.8M 53.8M n/a 3.5M 14.75M 14.75M
Common Stock Repurchased
-249K -8.3M -3.73M -3.62M -3.61M -3.58M -1.01M -981K -937K -915K -468K -616K -588K -585K -534K -365K -365K -365K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
564K 6.13M 1.73M -16K -16K -145K -604K 839K 680K 412K 25.22M 25.26M 25.42M 25.57M 781K 313K 2.13M 51.15M
Financial Cash Flow
315K -2.16M 36.17M 35.72M 35.73M 35.63M -428K 48.78M 48.66M 48.42M 127.47M 78.44M 78.63M 78.78M 27.25M 30.45M 43.51M 112.66M
Net Cash Flow
734K -4.35M 4.07M 12.99M 11.43M 11.78M -54.44M -33.54M -44.74M -48.44M 59.04M 24.62M 31.74M 37.17M 29.67M 21.61M -38.87M 27.36M
Free Cash Flow
-6.64M -27.43M -37.85M -33.45M -40.01M -44.56M -50.47M -72.88M -75.85M -81.38M -103.4M -116.22M -121.21M -120.63M -96.62M -78.64M -72.68M -76.35M